6835-IL) stimulates CXCL8/IL-8 secretion in the A431 human epithelial carcinoma cell line in a dose-dependent manner (orange line), as measured by the Human CXCL8/IL-8 Quantikine ELISA Kit (Catalog # D8000C). Il-8 Secretion elicited by Recombinant Human IL-36 gamma/IL-1F9 (aa 18-169) (30 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IL-1 Rrp2/IL-1 R6 Monoclonal Antibody (Catalog # MAB8721). The ND₅₀ is typically 0.25-1.5 µg/mL." class="big_lightbox"> 6835-IL) stimulates CXCL8/IL-8 secretion in the A431 human epithelial carcinoma cell line in a dose-dependent manner (orange line), as measured by the Human CXCL8/IL-8 Quantikine ELISA Kit (Catalog # D8000C). Il-8 Secretion elicited by Recombinant Human IL-36 gamma/IL-1F9 (aa 18-169) (30 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IL-1 Rrp2/IL-1 R6 Monoclonal Antibody (Catalog # MAB8721). The ND₅₀ is typically 0.25-1.5 µg/mL." alt="Recombinant Human IL-36 gamma/IL-1F9 (aa 18-169) (Catalog # 6835-IL) stimulates CXCL8/IL-8 secretion in the A431 human epithelial carcinoma cell line in a dose-dependent manner (orange line), as measured by the Human CXCL8/IL-8 Quantikine ELISA Kit (Catalog # D8000C). Il-8 Secretion elicited by Recombinant Human IL-36 gamma/IL-1F9 (aa 18-169) (30 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IL-1 Rrp2/IL-1 R6 Monoclonal Antibody (Catalog # MAB8721). The ND₅₀ is typically 0.25-1.5 µg/mL." class="big_thumb" />